US OptionsDetailed Quotes
NVO241206P101000
- 0.45
- -0.50-52.63%
15min DelayTrading Dec 2 14:08 ET
0.56High0.25Low
0.56Open0.95Pre Close49 Volume270 Open Interest101.00Strike Price2.12KTurnover63.80%IV7.72%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type-0.1213Delta0.0276Gamma242.13Leverage Ratio-0.1764Theta-0.0014Rho-29.37Eff Leverage0.0231Vega
Novo-Nordisk A/S Stock Discussion
The Commission concluded that the notified transaction would not raise competition concerns, given that the joint ventu...
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
New Positions
$Taiwan Semiconductor (TSM.US)$ , $Broadcom (AVGO.US)$ , $Johnson & Johnson (JNJ.US)$ , $Pfizer (PFE.US)$ , $Coca-Cola (KO.US)$ , $Occidental Petroleum (OXY.US)$
Sold out Positions
$Disney (DIS.US)$
Increased Positions
$Novo-Nordisk A/S (NVO.US)$ , $AstraZeneca (AZN.US)$ , $Huntington Ingalls Industries (HII.US)$
Decreased Positions
None
loading...
No comment yet